Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Phase I/II Study of the Safety, Tolerability and Efficacy of Belantamab Mafodotin (GSK2857916) in Combination with Iberdomide (CC-220)/Dexamethasone versus Belantamab Mafodotin (GSK2857916)/Dexamethasone in Relapsed Refractory Multiple Myeloma

Disease Sites:

Not Available

Staging:

Phase I/II

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Baljevic, Muhamed

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

06-23-2025

Trial Type:

Treatment

Protocol ID:

ALLPCLA062101

National Clinical Trial ID:

NCT06232044

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available